Multicentric trial of low molecular weight heparin (LMWH) plus low dose aspirin efficacy versus only low dose aspirin for prevention of recurrent preeclamsia. - ND
- Conditions
- previous preeclampsiaMedDRA version: 9.1Level: PTClassification code 10036485Term: Pre-eclampsia
- Registration Number
- EUCTR2008-005705-19-IT
- Lead Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Pregnant women before 8 weeks with previous preeclampsia untreated with anticoagulant and antiaggregant
Women in preconceptional period with previous preeclampsia untreated with anticoagulant and antiaggregant
Informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Normal pregnancy after a pregnancy complicated by preeclamsia
Acquired or inherited thrombophilia
Secondary chronic Hypertension
ASA allergy
Missing consent
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.